Evidence map›Paper›PMID 22433037›Full record

ArticleBioconjugate chemistry2012

Site-specific fluorescent labeling and oriented immobilization of a triple mutant of CYP3A4 via C64.

Amélie Ménard, Yue Huang, Pierre Karam, Gonzalo Cosa, Karine Auclair

Open access · greenAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Amélie MénardDepartment of Chemistry, McGill University, 801 Sherbrooke Street West, Montréal, Québec, Canada, H3A 0B8.
Yue Huang
Pierre Karam
Gonzalo Cosa
Karine Auclair
McGill University · CA

Funding

CIHR 85062
6 · The paper itself

Abstract

The generation of site-specific bioconjugates of proteins is highly desired for a number of biophysical and nanotechnological applications. To this end, many strategies have been developed that allow the specific modification of certain canonical amino acids and, more recently, noncanonical functional groups. P450 enzymes are heme-dependent monooxygenases involved in xenobiotic metabolism and in the biosynthesis of a variety of secondary metabolites. We became interested in the site-specific modification of these enzymes, CYP3A4 in particular, through our studies of their in vitro biocatalytic properties and our desire to exploit their remarkable ability to oxidize unactivated C-H bonds in a regio- and stereospecific manner. Obtained via a partial cysteine-depletion approach, a functional triple mutant of CYP3A4 (C98S/C239S/C468G) is reported here which is singly modified at C64 by maleimide-containing groups. While cysteine-labeling of the wild-type enzyme abolished >90% of its enzymatic activity, this mutant retained ≥75% of the activity of the unmodified wild-type enzyme with 9 of the 18 maleimides that were tested. These included both fluorescent and solid-supported maleimides. The loss of activity observed after labeling with some maleimides is attributed to direct enzyme inhibition rather than to steric effects. We also demonstrate the functional immobilization of this mutant on maleimide-functionalized agarose resin and silica microspheres.

Indexed as

MutationAmino Acid SequenceBinding SitesCysteineCytochrome P-450 CYP3AEnzymes, ImmobilizedFluorescent DyesHumansMaleimidesMicrospheresModels, MolecularMolecular Sequence DataMutant ProteinsProtein ConformationSilicon DioxideSubstrate SpecificityCYP3A4 protein, humanCysteineCytochrome P-450 CYP3AEnzymes, ImmobilizedFluorescent DyesmaleimideMaleimidesMutant ProteinsSilicon Dioxide

Identifiers

PMID22433037
PMCPMC5233439
OpenAlexW2312210365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.